CyGene Introduces Predictive Genetic Products in RussiaCategory: Press Releases | Permalink Published: Tuesday, August 04, 2009 CyGene Russia Inauguration Event
CORAL SPRINGS, Fla.--(BUSINESS WIRE)--CyGene Laboratories Inc. (OTC: CYGE - News) announced today that its direct-to-consumer predictive genetic products have been introduced in the Russian Federation by its exclusive licensee CyGene Russia, LLC. The CyGene products are the first predictive DNA tests for the Russian market. CyGene currently markets a variety of DNA predictive genetic test panels that provide consumers with information on genetic predisposition to treatable conditions. CyGene is the only consumer genetic testing provider that guarantees anonymity to its customers, while providing access to the most updated science at the lowest possible price. "We have great expectations for these new-age products that help consumers learn about themselves and make smart choices about their lifestyles," said Dmitri Nefedov, CEO of CyGene Russia at the company's inauguration party in Khabarovsk City. "The Russian people are eager to embrace the benefits that the next generation genetic technologies have to offer. We predict great success in this venture due to CyGene's superior business model and the ethical, cost-effective manner of introducing the science behind these products to the benefit of our citizens." Martin Munzer, CyGene's president and CEO, said, "We believe CyGene Russia will make a significant contribution to CyGene's commercial success. Mr. Nefedov has the long-term vision and leadership to successfully introduce our products and technologies into the highly receptive and educated Russian market." About CyGene Laboratories Inc.CyGene Laboratories Inc., based in Coral Springs, Fla., is a biotechnology company focused on introducing genetic predisposition and diagnostic testing into the general population. With five patents issued, CyGene's scientific expertise is in DNA analysis and diagnostic technologies. Incorporated in 1995, CyGene has been developing technology and introducing products that address the growing demand for genetic knowledge implementation and utilization. CyGene currently markets six DNA predictive genetic test panels in accordance with its patent pending business model, sold direct to consumers and through physicians and other healthcare practitioners. CyGene's process offers customers access to the most updated science, guaranteeing their anonymity and keeping consumers on the cutting edge of genetic discoveries at the lowest possible price. The method allows customers who have purchased a previous genetic test panel a low cost upgrade to their genetic report as new genetic discoveries become available. About CyGene Russia, LLCCyGene Russia represents the interests of CyGene Laboratories in the Russian Federation, including marketing and distributing its innovative genetic predisposition and diagnostic testing products. CyGene Russia is the first company to offer predictive DNA services to the Russian market. For more information about CyGene Laboratories and its products, visit the Company's Web site at: For more information about CyGene Russia and its products, visit the Company's Web site at: Contact:
Other Recent ArticlesInterest in CyGene DNA Consumer Testing Products Increases After Recent Media CoverageCategory: Press Releases Published: Wednesday, May 12, 2010 CyGene Labs announces that it has experienced unprecedented levels of interest and requests for information following recent media coverage of Walgreens' decision to offer genetic testing kits supplied by Pathway Genomics in certain of their retail stores. CyGene Laboratories Forms New International Sales OrganizationCategory: Press Releases Published: Wednesday, April 28, 2010 CyGene announces that it has formed an international sales organization. This new organization was formed to help expand the number of sales channels for the company’s multiple DNA test panels, which are primarily marketed to consumers. Rodolfo E. Gonzalez will be heading this new organization as the Director of Global Development. Los Angeles Times asks CyGene President Martin Munzer to Weigh in on Jamaican Sprinter Usain BoltCategory: Media Room Published: Friday, September 04, 2009 CyGene Laboratories is the industry leader in athletic performance genetic testing, helping everyone from professional athletes to weekend warriors achieve their optimal athletic goals. Company President Martin Munzer was recently quoted in an article appearing in the Los Angeles Times, weighing in on the athletic prowess of Jamaican sprinter Usain Bolt and how genetic testing is another tool for helping athletes achieve their goals. CyGene’s CEO To Speak At Russian Academy of Sciences Diagnostics ConferenceCategory: Press Releases Published: Friday, August 28, 2009 CyGene Russia, LLC, beginning to acquire recognition from the science circuit, has been invited to speak at the Russian Academy of Sciences diagnostics conference. CyGene’s CEO, Martin Munzer, will speak at the September 8th seminar and will cover “CyGene's products and technologies. CyGene is the first company to introduce predictive DNA tests and products to Russia, and the Vice President of the Far Eastern Public Academy of Sciences, Professor Iosif Piven, has high hopes for CyGene’s future. CyGene Laboratories Inc. New Customer-Focused WebsiteCategory: Press Releases Published: Thursday, August 27, 2009 CyGene Laboratories Inc. has launched a consumer friendly website, with creative direction from Infinity Arts, the new website is easy to understand and navigate. The new website offers detailed information regarding genetics, genetic risk factors, understanding your personal DNA and simple instructions on self dna analysis. The site also features links to the company's blog and its social media sites. |